Bachem AG and GlyTech, Inc. announce co-promotion agreement

Bachem AG and GlyTech, Inc. announce co-promotion agreement

Bubendorf/Basel, October 7, 2014 – Bachem the leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), the world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation...